Abbreviations: ACE, angiotensin-converting enzyme; RAS, renin-angiotensin system; ENOS, endothelial nitric oxide synthase; NO, nitric oxide; LAB, lactic acid bacteria; SHRs, spontaneously hypertensive rats; ECE, endothelin-1 and endothelin converting enzyme; ET, endothelin; MRW, met-Arg-Trp; FPI, flaxseed protein isolate; RPI, rapeseed protein isolate; BSFP, black-bone silky fowl muscle peptides; DBP, diastolic blood pressure; IER, inhibitory efficiency ratio; AHPM, antihypertensive peptide multimer
IntroductionHigh blood pressure or hypertension is a serious medical condition, caused due to a high flow of blood through the blood vessels with a force greater than normal. It strains the heart muscles and damages the blood vessels leading to stroke and finally death, if untreated.
1Untreated hypertension is usually associated with a progressive rise in blood pressure.2 It is the most common cause of morbidity and chronic metabolic disorders in the world. It is estimated to affect billions of individuals worldwide affecting 25% of most adult populations. 3,4 Hypertension as been called a silent killer as it has been implicated as the underlying cause for development of haemorrhagic stroke, cognitive decline, myocardial infarction, heart failure, chronic kidney disease and premature death.
5Hypertension may be classified as essential or secondary. Essential hypertension is the term for high blood pressure with no known etiological cause. Essential hypertension is caused by many factors:ii. lifestyle and environmental influences, andiii. disturbances in vascular structure and neuro-humoral control mechanisms.
5It accounts for about 95% of cases. Secondary hypertension is the term for high blood pressure associated with a known aetiology such as kidney disease, tumours or birth control pills. At present, it is widely accepted that approximately 30-50% of cases of hypertension can arise from genetic susceptibility. Monogenic forms of hypertension provide a unique opportunity to study the effects of single gene and identifying pathways and mechanisms leading to blood pressure elevation. 6 A number of pathways have been involved in the causation of hypertension amongst humans. Prominent among them are the pathways for fluid and electrolyte balance; the reninangiotensin system (RAS), the kinin-kallikrein system, the neutral endopeptidase system and the endothelin-converting enzyme system. Thus in clinical practice, vasodilators, diuretics, calcium channel blockers, angiotensin II receptor blockers and ACE inhibitors have been normally used as drugs.7 Most drugs target one or the other pathways to control hypertension. The response to drugs is varied and thus in non-responders may lead to metabolic disorders like diabetes, vascular blockage etc.Due to a high prevalence of hypertension among human population, a multipronged approach including changes in life-style, dietary approaches and pharmacological treatments is the need of the hour. Peptides of food origin have been reported to play an important prophylactic role in t...